RARE vs SFD · rev $350.0M vs P/E 9.6, rev $14.14B
Ultragenyx (RARE) versus Smithfield Foods, Inc. Common Stock (SFD) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
Smithfield Foods, Inc. Common Stock (SFD) is a packaged foods company listed on NASDAQ.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
Latest reported SFD revenue for 2024-12-29 was $14.14B. Net income was $970.0M. Revenue was down 3.4% from 2023-12-31 to 2024-12-29. SFD currently screens at market cap $9.75B and trailing P/E 9.6.
RARE currently screens at market cap $2.79B. SFD currently screens at market cap $9.75B and trailing P/E 9.6.
Not investment advice. Open the RARE and SFD stock pages for the full models.
Not investment advice.